Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

Bibliographic Details
Main Authors: Saad, Carla GS, Ribeiro, Ana CM, Moraes, Julio CB, Takayama, Liliam, Goncalves, Celio R, Rodrigues, Marcelo B, de Oliveira, Ricardo M, Silva, Clovis A, Bonfa, Eloisa, Pereira, Rosa MR
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580528/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580528/

Similar Items